| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥51.80B | -10.6% |
| Gross profit | ¥8.93B | — |
| Operating income | ¥8.05B | — |
| Net income | ¥6.88B | -48.0% |
| Gross margin | 17.2% | Net margin 13.3% |
| Revenue Q/Q | -0.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥42.87B | 82.8% |
| R&D | ¥0.26B | 0.5% |
| SG&A | ¥2.09B | 4.0% |
| Tax & other | ¥1.17B | 2.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
建设银行 ・ 中国核电 ・ 中国银行 ・ 中金公司 ・ 中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies